Clinical trial

Effects of RG1068 (Secretin) on Information Processing in Schizophrenia

NCT00235274

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE2

Study timeline

Study start (unknown)2005-11-01Date precision: month

Registry last updated2017-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Subcutaneous SecretinDRUG

Sponsors & collaborators

Indiana Universitylead sponsor

Shekhar, Anantha M.D., Ph.D.collaborator

Repligen Corporationcollaborator

Mapped research locations

IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00235274 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.